Noboru Kurinami 1,2,3* , Masafumi Takada 1* , Seigo Sugiyama 1,4 , Akira Yoshida 1 , Kunio Hieshima 1 , Tomoko Suzuki 1 , Fumio Miyamoto 1 , Keizo Kajiwara 1 , Katsunori Jinnouchi 1 , Kenji Ashida 2 , Masatoshi Nomura 2 , Hideaki Jinnouchi 1,5 Endocrinology and Metabolism 2025;40(6):1012-1015
Identification of enhanced serine kinase activity in insulin resistance
Its also been approved for treating moderate to advanced liver fibrosis associated with metabolic dysfunction-associated steatohepatitis (MASH)
These combined effects contribute to improved blood sugar control and a reduction in caloric intake
On August 2, 2023, a lawsuit was filed against Novo Nordisk and Eli Lilly and Company, the manufacturers of the drugs, by Jaclyn Bjorklund, a 44-year-old woman from Louisiana